Vyome Therapeutics Inc CEO Venkat Nelabhotla sat down with Proactive Investors at the BIO CEO & Investor Conference in New York.
Vyome Therapeutics is a clinical stage speciality pharmaceutical company, with platform technologies and a pipeline of drugs for antibiotic-resistant acne and other skin pathogens.
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE
Bam Bam Resources (CSE: BBR- OTC: NPEZF) CEO David Greenway shares news with Steve Darling from Proactive that the company has been able to increase its position on the Majuba Hill Project by 75%. Greenway telling Proactive, the company added 168 new, unpatented lode mining claims...
Basic Materials
CO2 GRO sees 20% higher pepper yields though 10 weeks of Hidroexpo...
Mining
Retail & consumer
Prev article
